Viramal

London, United Kingdom Founded: 2013 • Age: 13 yrs
Viramal is focused on developing transformative medicines for women.

About Viramal

Viramal is a company based in London (United Kingdom) founded in 2013. It operates as a HealthTech. The company has 13 employees as of April 30, 2022. Viramal offers products and services including Transdermal Therapies and Vaginal Well-being Products. Viramal operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter London, United Kingdom
  • Employees 13 as on 30 Apr, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Viramal Limited
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    13

    as on Apr 30, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Viramal

Viramal offers a comprehensive portfolio of products and services, including Transdermal Therapies and Vaginal Well-being Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Innovative transdermal treatments for women's health conditions.

Products focused on maintaining vaginal health effectively.

People of Viramal
Headcount
Employee Profiles 3
Employee Profiles
People
Oliver Bates
Chief Executive Officer and Co-Founder

Unlock access to complete

Teams

Funding Insights of Viramal

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2018 Amount Series A - Viramal Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Viramal

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Viramal

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Viramal Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Viramal

Viramal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Viramal

Frequently Asked Questions about Viramal

When was Viramal founded?

Viramal was founded in 2013 and raised its 1st funding round 5 years after it was founded.

Where is Viramal located?

Viramal is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

How many employees does Viramal have?

As of Apr 30, 2022, the latest employee count at Viramal is 13.

What does Viramal do?

Viramal, a specialist pharmaceutical company, is engaged in creating innovative biological and vaginal well-being products for women. Based in the UK and Sweden, the company is dedicated to addressing neglected areas of womens sexual and reproductive health. Solutions are developed for conditions such as endometriosis, menopause, and chronic pelvic pain through proprietary transdermal and trans-vaginal technologies. A safer medical approach is prioritized to minimize side effects while maximizing efficacy. The portfolio includes both prescription and non-prescription treatments aimed at improving womens quality of life across various life stages.

Who are the top competitors of Viramal?

Viramal's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

What products or services does Viramal offer?

Viramal offers Transdermal Therapies and Vaginal Well-being Products.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available